Rebekah Jordan spoke with Katrin Pauls (Lonza), Mark Hilhorst (Jekson Vision), and Christoph Jansen (Mettler Toledo), to discuss the factors and challenges involved in the pharma industry's move towards sustainable, future-proofed QC lab testing.
EPM's Q&A with Jack Dix, head of healthcare strategy and consulting at Kainos, examines technology in genomics research and how cloud data transformation can help to build better patient outcomes.
Paul Smaltz, vice president, pharmaceuticals, at Roquette, explores how taking a more ‘human’ look at the issue of drug shortages and supply chain resilience could help the industry find the fresh ideas it needs to tackle this pressing problem.
A recent panel debate moderated by Christian K. Schneider, head of Biopharma Excellence, explored emerging approaches to clinical research and data collection for therapies linked to rare diseases.
The ideas behind the pharma sector date back to the apothecaries of the middle ages. A naturally progressive industry, pharma has drawn together some great thinkers and speakers
EPM fires some questions with Neil Ward, PacBio, to learn of the trends of 2023, and how its HiFi genome sequencing technology will be used in collaboration with Boston Children's Hospital to uncover novel mutations in rare paediatric diseases.
This Saturday marked International Day of Woman and Girls in Science and Jane Kennedy, chief business officer, Discovery Park, asks why women in this sector are still excluded from funding and leadership positions.
As the life sciences sector grapples with a rapidly changing environment and increasing regulatory scrutiny, Frits Stulp of Iperion – a Deloitte business, predicts that harnessing the power of digital transformation can optimise patient outcomes.
Jason Boyd, senior director, Vault LIMS, Veeva Systems, gives three ways in which digital strategies can modernise quality control by creating a holistic view of workflow and quality data in biopharma lab operations.
Natalie DiMambro, VP product commercialisation and training, Within3, explores the technologies and trends that are causing leaders to redefine current practices and invest more heavily in innovation to stay ahead of the curve in 2023.
